Actuate Therapeutics, Inc. $ACTU

By Microcap Ledger desk · CIK 0001652935

Facts as of Oct 11, 2026, 06:08 AM UTC. Built from SEC filings and our own data. Small caps move fast; check the latest filings.

This page is still filling in. We publish more sections as filings are processed.

Snapshot

Exchange: Nasdaq Global Market
Sector: Pharmaceutical Preparations
Headquarters: Fort Worth, TX
Fiscal year end: December 31
Shares outstanding: 24,014,202 [10-Q 2026-08-14]
as of 2026-08-13

Sources: [10-K 2026-03-26]

Financial health

From XBRL company facts (USD)
Period	Revenue	Net income	Operating cash flow	Cash	Filing
6 months to Jun 2026	—	−$10.49M	−$9.42M	$4.43M	[10-Q 2026-08-14]
FY ended Dec 2025	—	−$22.23M	−$19.21M	$13.16M	[10-K 2026-03-26]
FY ended Dec 2024	—	−$27.29M	−$21.84M	$8.64M	[10-K 2026-03-26]

Quarterly cash burn: −$4.71M
Cash runway Estimate: ~2.8 months

Capital structure and dilution

Summary only. How these instruments work: Dilution & financing desk.

Share count
Date	Shares outstanding	Filing
2024-11-11	19,531,636	[10-Q 2024-11-13]
2025-03-10	19,531,636	[10-K 2025-03-13]
2025-05-14	19,619,660	[10-Q 2025-05-15]
2025-08-13	20,745,187	[10-Q 2025-08-14]
2025-11-12	23,243,328	[10-Q 2025-11-13]
2026-03-25	23,709,943	[10-K 2026-03-26]
2026-05-13	23,925,852	[10-Q 2026-05-14]
2026-08-13	24,014,202	[10-Q 2026-08-14]

Shelf registration: S-1 filed 2026-10-06; no effectiveness notice found in EDGAR [S-1 2026-10-06]

Listing status

Current status: 1 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2026-07-17. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.

Date	Event	Details	Deadline	Filing
2026-07-17	8-K Item 3.01	Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing	—	[8-K 2026-07-17]

More on deficiency notices and uplistings: Listing status desk.

Who owns it

Recent Form 4 transactions
Date	Insider	Type	Shares	Price	Filing
2026-08-14	Schmitt Daniel M	exercise	272,056	—	[4 2026-08-14]
2026-08-14	Schmitt Daniel M	other	120,521	$1.01	[4 2026-08-14]

Catalysts and calendar

Recent filings and releases
Date	Type	Title
2026-10-06	S-1	Registration statement
2026-08-14	10-Q	Quarterly report
2026-07-17	8-K	Listing notice or transfer
2026-05-22	8-K	Shareholder vote results
2026-05-14	10-Q	Quarterly report
2026-05-11	8-K	Regulation FD disclosure
2026-05-06	8-K	Director or officer change; Other events
2026-04-22	13G/A	Beneficial ownership report (5%+ holder)
2026-04-06	DEF 14A	Proxy statement
2026-03-26	10-K	Annual report
2026-01-12	8-K	Regulation FD disclosure
2025-12-17	13G	Beneficial ownership report (5%+ holder)

Facts as of Oct 11, 2026, 06:08 AM UTC. Small caps move fast; check the latest filings.